VanEck Biotech ETF (NASDAQ:BBH) Sees Unusually-High Trading Volume – Here’s Why

Shares of VanEck Biotech ETF (NASDAQ:BBH) saw unusually-high trading volume on Thursday. Approximately 4,806 shares changed hands during trading, a decline of 34% from the previous session’s volume of 7,289 shares. The stock last traded at $251.1030 and had previously closed at $250.46.

VanEck Biotech ETF Trading Down 1.4%

The firm has a fifty day simple moving average of $237.94 and a 200 day simple moving average of $210.07.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in BBH. Coastline Trust Co purchased a new stake in shares of VanEck Biotech ETF in the 3rd quarter valued at approximately $46,000. CoreCap Advisors LLC acquired a new position in shares of VanEck Biotech ETF in the 3rd quarter valued at $46,000. SBI Securities Co. Ltd. purchased a new position in VanEck Biotech ETF during the 3rd quarter worth approximately $74,000. First PREMIER Bank acquired a new stake in VanEck Biotech ETF during the 2nd quarter worth approximately $91,000. Finally, JNBA Financial Advisors acquired a new stake in VanEck Biotech ETF in the second quarter valued at about $122,000. 32.05% of the stock is owned by institutional investors and hedge funds.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.